Exact Mass: 559.1842224000001
Exact Mass Matches: 559.1842224000001
Found 145 metabolites which its exact mass value is equals to given mass value 559.1842224000001
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Neoacrimarine K
Neoacrimarine K is found in citrus. Neoacrimarine K is an alkaloid from the roots of Citrus paradisi (grapefruit). Alkaloid from the roots of Citrus paradisi (grapefruit). Neoacrimarine K is found in citrus.
Infigratinib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EN - Fibroblast growth factor receptor (fgfr) tyrosine kinase inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164035 - FGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C155727 - FGFR Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor D000970 - Antineoplastic Agents
8-(5-Chloro-2-(4-methylpiperazin-1-yl)isonicotinamido)-1-(4-fluorophenyl)-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide
Cys Asp His Trp
Cys Asp Trp His
Cys Phe Gln Tyr
C26H33N5O7S (559.2100588000001)
Cys Phe Tyr Gln
C26H33N5O7S (559.2100588000001)
Cys His Asp Trp
Cys His Trp Asp
Cys Gln Phe Tyr
C26H33N5O7S (559.2100588000001)
Cys Gln Tyr Phe
C26H33N5O7S (559.2100588000001)
Cys Trp Asp His
Cys Trp His Asp
Cys Tyr Phe Gln
C26H33N5O7S (559.2100588000001)
Cys Tyr Gln Phe
C26H33N5O7S (559.2100588000001)
Asp Cys His Trp
Asp Cys Trp His
Asp His Cys Trp
Asp His Trp Cys
Asp Trp Cys His
Asp Trp His Cys
Glu Glu Pro Trp
Glu Glu Trp Pro
Glu Pro Glu Trp
Glu Pro Trp Glu
Glu Trp Glu Pro
Glu Trp Pro Glu
Phe Cys Gln Tyr
C26H33N5O7S (559.2100588000001)
Phe Cys Tyr Gln
C26H33N5O7S (559.2100588000001)
Phe Gln Cys Tyr
C26H33N5O7S (559.2100588000001)
Phe Gln Tyr Cys
C26H33N5O7S (559.2100588000001)
Phe Tyr Cys Gln
C26H33N5O7S (559.2100588000001)
Phe Tyr Gln Cys
C26H33N5O7S (559.2100588000001)
His Cys Asp Trp
His Cys Trp Asp
His Asp Cys Trp
His Asp Trp Cys
His Met Ser Trp
His Met Trp Ser
His Ser Met Trp
His Ser Trp Met
His Trp Cys Asp
His Trp Asp Cys
His Trp Met Ser
His Trp Ser Met
Met His Ser Trp
Met His Trp Ser
Met Ser His Trp
Met Ser Trp His
Met Trp His Ser
Met Trp Ser His
Asn Thr Tyr Tyr
Asn Tyr Thr Tyr
Asn Tyr Tyr Thr
Pro Glu Glu Trp
Pro Glu Trp Glu
Pro Trp Glu Glu
Gln Cys Phe Tyr
C26H33N5O7S (559.2100588000001)
Gln Cys Tyr Phe
C26H33N5O7S (559.2100588000001)
Gln Phe Cys Tyr
C26H33N5O7S (559.2100588000001)
Gln Phe Tyr Cys
C26H33N5O7S (559.2100588000001)
Gln Ser Tyr Tyr
Gln Tyr Cys Phe
C26H33N5O7S (559.2100588000001)
Gln Tyr Phe Cys
C26H33N5O7S (559.2100588000001)
Gln Tyr Ser Tyr
Gln Tyr Tyr Ser
Ser His Met Trp
Ser His Trp Met
Ser Met His Trp
Ser Met Trp His
Ser Gln Tyr Tyr
Ser Trp His Met
Ser Trp Met His
Ser Tyr Gln Tyr
Ser Tyr Tyr Gln
Thr Asn Tyr Tyr
Thr Tyr Asn Tyr
Thr Tyr Tyr Asn
Trp Cys Asp His
Trp Cys His Asp
Trp Asp Cys His
Trp Asp His Cys
Trp Glu Glu Pro
Trp Glu Pro Glu
Trp His Cys Asp
Trp His Asp Cys
Trp His Met Ser
Trp His Ser Met
Trp Met His Ser
Trp Met Ser His
Trp Pro Glu Glu
Trp Ser His Met
Trp Ser Met His
Tyr Cys Phe Gln
C26H33N5O7S (559.2100588000001)
Tyr Cys Gln Phe
C26H33N5O7S (559.2100588000001)
Tyr Phe Cys Gln
C26H33N5O7S (559.2100588000001)
Tyr Phe Gln Cys
C26H33N5O7S (559.2100588000001)
Tyr Asn Thr Tyr
Tyr Asn Tyr Thr
Tyr Gln Cys Phe
C26H33N5O7S (559.2100588000001)
Tyr Gln Phe Cys
C26H33N5O7S (559.2100588000001)
Tyr Gln Ser Tyr
Tyr Gln Tyr Ser
Tyr Ser Gln Tyr
Tyr Ser Tyr Gln
Tyr Thr Asn Tyr
Tyr Thr Tyr Asn
Tyr Tyr Asn Thr
Tyr Tyr Gln Ser
Tyr Tyr Ser Gln
Tyr Tyr Thr Asn
Neoacrimarine K
4-(4-METHYLTHIOPHEN-2-YL)-N-(4-(MORPHOLINOMETHYL)PHENYL)-7-TOSYL-7H-PYRROLO[2,3-D]PYRIMIDIN-2-AMINE
LY2608204
D020536 - Enzyme Activators
1-Methyl-3-Tetradecylimidazolium Bis(Trifluoromethylsulfonyl)Imide
C20H35F6N3O4S2 (559.1973062000001)
DIMETHYL 2-(5-CYANO-5-FORMYL-2,6-BIS((2-METHOXYETHOXY)METHOXY)-[1,1-BIPHENYL]-3-YL)SUCCINATE
2-(dimethylamino)-2-biphenylyl-palladium(ii) chloride dinorbornylphosphine complex
C28H37ClNPPd (559.1386752000001)
7-[(3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazine (-)-mandelate
(S)-(-)-4-[2-(DIPHENYLPHOSPHINO)-1-NAPHTHALENYL]-N-[?-1-PHENYLETHYL]-1-PHTHALAZINAMINE,(S)-N-PINAP
(R)-(+)-4-[2-(DIPHENYLPHOSPHINO)-1-NAPHTHALENYL]-N-[?-1-PHENYLETHYL]-1-PHTHALAZINAMINE, MIN.(R)-N-PINAP
4-aMino-1-((2R,3R,4R,5R)-5-((bis(4-Methoxyphenyl)(phenyl)Methoxy)Methyl)-4-hydroxy-3-Methoxytetrahydrofuran-2-yl)pyriMidin-2(1H)-one
C31H33N3O7 (559.2318388000001)
8-(5-Chloro-2-(4-methylpiperazin-1-yl)isonicotinamido)-1-(4-fluorophenyl)-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide
Infigratinib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EN - Fibroblast growth factor receptor (fgfr) tyrosine kinase inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164035 - FGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C155727 - FGFR Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor D000970 - Antineoplastic Agents
[6-(Diethylamino)-9-(2,4-disulfophenyl)xanthen-3-ylidene]-diethylazanium
2-[(2R,4aS,12aS)-5-methyl-6-oxo-8-(2,2,2-trifluoroethylsulfonylamino)-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(3-fluorophenyl)acetamide
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-{[1-(6,7-dimethoxy-2H-1,3-benzodioxol-5-yl)-2-hydroxy-3-oxopropyl]sulfanyl}ethyl}-C-hydroxycarbonimidoyl)butanoic acid
C22H29N3O12S (559.1471874000001)